Ads
related to: recent findings of statin drugs and memory loss
Search results
Results From The WOW.Com Content Network
A new way of determining heart disease risk may result in millions fewer people getting prescriptions for statins, according to new research. Heart doctors warned, however, that more information ...
In March 2012, the U.S. Food and Drug Administration (FDA) updated its guidance for statin users to address reports of memory loss, liver damage, increased blood sugar, development of type 2 diabetes, and muscle injury. [26] The new guidance indicates: FDA has found that liver injury associated with statin use is rare but can occur. [citation ...
The new study supports this conclusion, finding no link between statins, myopathy, muscle pain, or liver dysfunction, another possible adverse effect of the drugs.
An alternative to statins may help reduce deaths from heart disease among people with high levels of LDL, or “bad” cholesterol, new research finds.. When taken as a daily pill, bempedoic acid ...
The U.S. Food and Drug Administration (FDA) notified healthcare professionals of updates to the prescribing information concerning interactions between protease inhibitors and certain statin drugs. Protease inhibitors and statins taken together may increase the blood levels of statins and increase the risk for muscle injury (myopathy).
Research on statins (cholesterol-lowering drugs) and cinnamon Kalipada Pahan (born 19 February 1964; Midnapore ) is a professor of Neurological Sciences , Biochemistry and Pharmacology , and the Floyd A. Davis, M.D., Endowed Chair in Neurology at the Rush University Medical Center .
JUPITER was a randomized double-blind placebo-controlled study investigating the use of rosuvastatin in the primary prevention of cardiovascular disease.The trial focused on patients with normal low-density lipoprotein (LDL) cholesterol levels but increased levels of high-sensitivity C-reactive protein (hs-CRP).
For premium support please call: 800-290-4726 more ways to reach us